Wednesday's UK broker ratings

Updated every day, our UK broker ratings identify which FTSE- and AIM-listed companies are affected by a ratings change.

Listed below are details of selected companies that have undergone a ratings change today. Alternatively, download the pdf to see a full list of today's UK broker ratings.

UK broker ratings (9KB)


Pdfs require Adobe Reader, which is available free from  Adobe.

 

Upgrade

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Dialight Buy 1190 30.8% Kempen & Co
Kcom Group Overweight 115 10.2% JPMorgan
WH Smith Overweight 1085 9.4% JPMorgan

 

Maintain

Company

Rating

Target price

Potential upside/Downside

Contributing broker

William Hill Buy 550 49.7% Numis Securities Ltd
Afren Outperform 225 41.6% Exane BNP Paribas
EnQuest Buy 188 38.0% Liberum Capital Ltd

 

New rating

Company

Rating

Target price

Potential upside/Downside

Contributing broker

Taylor Wimpey Overweight 147 36.5% Barclays
Barratt Developments Overweight 445 36.1% Barclays
Redrow Overweight 356 32.6% Barclays

 

Source: Bloomberg (20 November 2013)

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.